CYP cynata therapeutics limited

Do try not to be misleading in your analysis. You may have heard...

  1. 9,299 Posts.
    lightbulb Created with Sketch. 7982
    Do try not to be misleading in your analysis. You may have heard of sample size amongst your trolling. n=1 doesn't really past muster Pledge. Thought you'd have worked that out by now. Do be thorough and tell us all of the ones discussed (this not even recent):

    "Most recently, IQVIA released a report finding that 25 of 59 (42%) novel drugs approved in 2018 were approved on the basis of only one trial. And one out of eight approvals relied only on Phase 1 or 2 trials, with no Phase 3 trials. But as in previous years, a large portion of the drugs relying on only one trial were new orphan and cancer drugs."

    https://www.raps.org/News-and-Articles/News-Articles/2019/5/Almost-Half-of-All-New-Drug-Approvals-in-2018-Reli

    Your actual one example OF MANY actually even refutes your very statement above of none reaching commercialisation:

    "the company will remove the drug from market".

    Ergo it was in the market. You can't even read your own reports properly that prove exactly your earlier statement as incorrect.

    So yeah, "next".
    Last edited by bedger: 20/12/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.